Does Biondvax Pharmaceuticals Ltd - ADR (BVXV) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, November 30, 2022 10:36 AM | InvestorsObserver Analysts

Mentioned in this article

Does Biondvax Pharmaceuticals Ltd - ADR (BVXV) Have What it Takes to be in Your Portfolio Wednesday?

Biondvax Pharmaceuticals Ltd - ADR (BVXV) is near the top in its industry group according to InvestorsObserver. BVXV gets an overall rating of 77. That means it scores higher than 77 percent of stocks. Biondvax Pharmaceuticals Ltd - ADR gets a 92 rank in the Biotechnology industry. Biotechnology is number 57 out of 148 industries.

BVXV has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on BVXV!

See Full BVXV Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 77 would rank higher than 77 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Biondvax Pharmaceuticals Ltd - ADR Stock Today?

Biondvax Pharmaceuticals Ltd - ADR (BVXV) stock is up 1.68% while the S&P 500 is lower by -0.26% as of 10:22 AM on Wednesday, Nov 30. BVXV is up $0.16 from the previous closing price of $9.55 on volume of 6,027 shares. Over the past year the S&P 500 is down -13.57% while BVXV is lower by -43.55%. BVXV lost -$8.35 per share the over the last 12 months. Click Here to get the full Stock Report for Biondvax Pharmaceuticals Ltd - ADR stock.